Opus Genetics, Inc. (IRD)

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32.43	30.32	50.5	42.63	24.53	16.4
Short-Term Investments	-	0	0.02	0.05	0.22	-
Cash & Short-Term Investments	32.43	30.32	50.52	42.68	24.75	16.4
Cash Growth	-21.70%	-39.97%	18.35%	72.44%	50.94%	966.95%
Accounts Receivable	4.58	5.77	2.33	4.85	-	-
Other Current Assets	1.43	0.52	1.1	1.45	1.31	1.27
Total Current Assets	38.44	36.61	53.95	48.99	26.07	17.67
Net Property, Plant & Equipment	0.23	0.25	-	0.01	0.01	0.01
Total Assets	38.67	36.86	53.95	48.99	26.08	17.68
Accounts Payable	1.47	3.15	2.15	1.07	1.58	1.21
Accrued Expenses	6.93	8.15	1.82	1.68	1.73	1.97
Short-Term Debt	-	-	-	-	0.54	-
Other Current Liabilities	11.8	-	0.07	-	-	-
Total Current Liabilities	20.19	11.3	4.04	2.75	3.86	3.19
Long-Term Debt	1	-	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	27.96
Total Long-Term Liabilities	1	-	-	-	-	27.96
Total Liabilities	21.19	11.3	4.04	2.75	3.86	31.15
Common Stock	0.01	0	0	0	0	0
Additional Paid-in Capital	172.08	145.72	131.37	117.72	111.59	19.21
Retained Earnings	-154.61	-139	-81.47	-71.48	-89.37	-32.68
Total Common Shareholders' Equity	17.47	6.72	49.91	46.24	22.22	-13.47
Minority Interest	-	18.84	-	-	-	-
Shareholders' Equity	17.47	6.72	49.91	46.24	22.22	-13.47
Total Liabilities & Equity	38.67	36.86	53.95	48.99	26.08	17.68
Total Debt	1	0	0	0	0.54	0
Net Cash (Debt)	31.43	30.32	50.52	42.68	24.22	16.4
Net Cash Growth	3.65%	-39.97%	18.35%	76.27%	47.66%	-
Net Cash Per Share	0.82	1.14	2.34	2.07	1.63	3.52
Book Value	17.47	6.72	49.91	46.24	22.22	-13.47
Book Value Per Share	0.45	0.25	2.31	2.24	1.50	-2.89
Tangible Book Value	17.47	6.72	49.91	46.24	22.22	-13.47
Tangible Book Value Per Share	0.45	0.25	2.31	2.24	1.50	-2.89

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q